Elizabeth A Thiele Selected Research

Sleepiness

1/2021	Add-on Cannabidiol Treatment for Drug-Resistant Seizures in Tuberous Sclerosis Complex: A Placebo-Controlled Randomized Clinical Trial.
1/2017	Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Elizabeth A Thiele Research Topics

Disease

66	Tuberous Sclerosis (Bourneville's Disease) 11/2023 - 10/2002
44	Epilepsy (Aura) 01/2023 - 09/2002
26	Seizures (Absence Seizure) 01/2022 - 09/2005
21	Drug Resistant Epilepsy 01/2022 - 02/2005
12	Neoplasms (Cancer) 11/2023 - 02/2004
12	Infantile Spasms (West Syndrome) 08/2016 - 07/2005
9	Angiomyolipoma 09/2022 - 10/2002
9	Inborn Genetic Diseases (Disease, Hereditary) 10/2016 - 12/2009
6	Lennox Gastaut Syndrome 01/2021 - 07/2010
5	Myoclonic Epilepsies (Myoclonic Encephalopathy) 01/2021 - 01/2017
5	Astrocytoma (Pilocytic Astrocytoma) 01/2021 - 10/2004
3	Angiofibroma 09/2022 - 01/2011
3	Hamartoma 01/2022 - 10/2002
3	Giant Cell Tumors (Giant Cell Tumor) 07/2020 - 10/2004
3	Autism Spectrum Disorder 01/2020 - 02/2013
3	Spasm (Spasms) 01/2020 - 02/2009
3	Lymphangioleiomyomatosis (Lymphangiomyomatosis) 01/2019 - 09/2015
3	Angelman Syndrome (Syndrome, Angelman) 01/2017 - 09/2012
3	Cognitive Dysfunction 11/2010 - 12/2007
3	Acidosis 06/2010 - 05/2002
2	Primitive Neuroectodermal Tumors (PNET) 11/2023 - 01/2022
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 11/2023 - 01/2022
2	Fatigue 01/2023 - 01/2017
2	Cysts 01/2022 - 12/2009
2	Brain Neoplasms (Brain Tumor) 01/2021 - 01/2011
2	Diarrhea 01/2021 - 01/2017
2	Sleepiness 01/2021 - 01/2017
2	Fever (Fevers) 01/2017 - 01/2013
2	Neurologic Manifestations (Neurological Manifestations) 10/2016 - 12/2007
2	Lymphedema (Milroy Disease) 09/2015 - 06/2014
2	Rhabdomyoma 07/2013 - 01/2011
2	Autistic Disorder (Autism) 02/2013 - 12/2007
2	Ketosis 09/2011 - 05/2009
1	Pulmonary Hypertension 01/2023
1	Disease Progression 01/2022
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2022
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Glioma (Gliomas) 01/2021
1	Ganglioglioma 01/2021
1	Glioblastoma (Glioblastoma Multiforme) 01/2021
1	Chemical and Drug Induced Liver Injury 01/2018
1	Fibroma (Fibromatosis) 01/2018
1	Perivascular Epithelioid Cell Neoplasms 01/2018
1	Intestinal Volvulus (Volvulus) 01/2018
1	CDKL5 deficiency disorder 01/2018
1	Onchocerciasis 09/2017
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2017
1	Body Weight (Weight, Body) 01/2017
1	Vomiting 01/2017
1	Lung Diseases (Lung Disease) 12/2015
1	Thyroid Neoplasms (Thyroid Cancer) 12/2015
1	Thyroid Diseases (Thyroid Disease) 12/2015
1	Obesity 02/2015
1	Gastroesophageal Reflux (GERD) 02/2015
1	Constipation 02/2015
1	Scoliosis 02/2015
1	Sturge-Weber Syndrome (Sturge-Kalischer-Weber Syndrome) 08/2014

Drug/Important Bio-Agent (IBA)

59	trans-sodium crocetinate (crocetin)IBA 11/2023 - 10/2002
19	CannabidiolIBA 01/2023 - 06/2014
17	Anticonvulsants (Antiepileptic Drugs)IBA 01/2021 - 05/2007
6	Vigabatrin FDA Link 08/2016 - 07/2008
5	Sirolimus (Rapamycin)FDA Link 01/2022 - 01/2011
4	Clobazam (HR 376)IBA 12/2020 - 05/2013
4	lipoarabinomannan (LAM)IBA 01/2019 - 01/2011
4	Biomarkers (Surrogate Marker)IBA 01/2017 - 10/2005
3	DNA (Deoxyribonucleic Acid)IBA 11/2019 - 11/2015
3	TOR Serine-Threonine KinasesIBA 03/2016 - 04/2010
2	FenfluramineIBA 01/2023 - 12/2021
2	Investigational DrugsIBA 01/2022 - 08/2015
2	Everolimus FDA Link 01/2022 - 01/2013
2	Mechanistic Target of Rapamycin Complex 1IBA 01/2021 - 04/2010
2	Tuberous Sclerosis Complex 2 ProteinIBA 01/2021 - 02/2004
2	SolutionsIBA 07/2020 - 01/2017
2	Valproic Acid (Depakote)FDA LinkGeneric 01/2018 - 09/2005
2	EnzymesIBA 01/2017 - 04/2013
2	CarbohydratesIBA 01/2017 - 09/2012
2	MTOR InhibitorsIBA 03/2016 - 01/2016
2	Vascular Endothelial Growth Factor DIBA 01/2013 - 01/2011
2	Topiramate (Topamax)FDA LinkGeneric 06/2010 - 09/2002
2	Glucose (Dextrose)FDA LinkGeneric 05/2009 - 05/2002
2	Bicarbonates (Hydrogen Carbonate)IBA 09/2002 - 05/2002
1	Retinaldehyde (Retinal)IBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Tuberous Sclerosis Complex 1 ProteinIBA 01/2021
1	N-desmethylclobazam (norclobazam)IBA 01/2020
1	CannabinoidsIBA 01/2020
1	EndostatinsIBA 01/2019
1	DesminIBA 01/2018
1	Transaminases (Aminotransferases)IBA 01/2018
1	AntigensIBA 09/2017
1	ApolipoproteinsIBA 01/2017
1	Apolipoproteins B (ApoB)IBA 01/2017
1	Lacosamide FDA Link 05/2015

Therapy/Procedure

18	Therapeutics 01/2020 - 09/2002
14	Ketogenic Diet 06/2018 - 09/2002
1	Patient Transfer (Patient Dumping) 10/2022
1	Withholding Treatment 01/2022
1	Mass Drug Administration 01/2018
1	Dental Care 02/2015
1	Transition to Adult Care 08/2014